Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 124, 2004 - Issue 8
Submit an article Journal homepage
43
Views
9
CrossRef citations to date
0
Altmetric
Nose/Sinus

Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro

Mayumi Namba From the Departments of Otolaryngology, Showa University, School of Medicine, Tokyo, Japan
,
Kazuhito Asano Physiology, Showa University, School of Medicine, Tokyo, Japan
,
Ken-Ichi Kanai From the Departments of Otolaryngology, Showa University, School of Medicine, Tokyo, Japan
,
Yoshiyuki Kyo From the Departments of Otolaryngology, Showa University, School of Medicine, Tokyo, Japan
,
So Watanabe From the Departments of Otolaryngology, Showa University, School of Medicine, Tokyo, Japan
,
Tadashi Hisamitsu Physiology, Showa University, School of Medicine, Tokyo, Japan
&
Harumi Suzaki From the Departments of Otolaryngology, Showa University, School of Medicine, Tokyo, JapanCorrespondence[email protected]
 show all
Pages 964-969 | Received 11 Jul 2003, Accepted 06 Nov 2003, Published online: 08 Jul 2009

References

  • Kramer MF, Rasp G. Nasal polyposis: eosinophils and interleukin-5. Allergy 1999; 54: 669–80.
  • Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996; 17: 231–6.
  • Norlander T, Westrin KM, Fukami M, Stierna P, Carlsoo B. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope 1996; 106: 196–203.
  • Powers MR, Qu Z, LaGesse PC, Liebler JM, Wall MA, Rosenbaum JT. Expression of basic fibroblast growth factor in nasal polyps. Ann Otol Rhinol Laryngol 1998; 107: 891–7.
  • Nonaka M, Pawankar R, Saji F, Yagi T. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl (Stockh) 1998; 539: 71–5.
  • Lechapt-Zalcman E, Coste A, d'Ortho MP, Frisdal E, Harf A, Lafuma C, Escudier E. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001; 193: 233–41.
  • Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular ma-trix. Am J Pathol 1996; 148: 1345–50.
  • Herouy Y, Mellios P, Bandemir E, Dichmann S, Nock-owski P, Schopf E. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci 2001; 25: 198–205.
  • Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16: 212–9.
  • Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998; 102: 783–8.
  • Mygind N, Naclerio RM. Intranasal corticosteroids. In: Naclerio RM, Durham SR, Mygind N, eds. Rhinitis: mechanisms and management. New York: Marcel Dekker; 1999. p. 221–65.
  • Bolard F, Gosset P, Lamblin C, Bergoin C, Tonnel AB, Wallaert B. Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment. Allergy 2001; 56: 333–8.
  • Cataldo DD, Tournoy KG, Vermaelen K, Munaut C, Foidart JM, Louis R. Matrix metalloproteinase-9 defi-ciency impairs cellular infiltration and bronchial hyper-responsivenessduringallergen-inducedairwayinflammation. Am J Pathol 2002; 161: 491–8.
  • Forsgren K, Fukami S. Endoscopic and Caldwell-Luc approaches in chronic maxillary sinusitis: a comparable histopathologic study on preoperative and postoperative mucosal morphology. Ann Otol Rhinol Laryngol 1995; 104: 350–7.
  • Al-Rawi MM, Edelstein DR, Erlandson RA. Changes in nasal epithelium in patients with severe chronic sinusitis: a clinicopathologic and electron microscopic study. Laryngoscope 1998; 108: 1816–23.
  • Majima Y, Masuda S, Sakakura Y. Quantitative study of nasal secretory cells in normal subjects and patients with chronic sinusitis. Laryngoscope 1997; 107: 1515–8.
  • Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity allergen challenge, and inhaled corticosteroids. Chest 2002; 122: 1543–52.
  • Bosse M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M. Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999; 159: 596–602.
  • Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A. Matrix metallo-proteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197–250.
  • Burnstein KL, Cidlowski JA. At the cutting edge: the down side of glucocorticoid receptor regulation. Mol Cell Endocrinol 1992; 83: C1–8.
  • Knutsson PU, Bronnegard M, Marcus C, Stierna P. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide. J Allergy Clin Immunol 1996; 97: 655–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.